Pituitary tumor: Difference between revisions
No edit summary |
m (Bot: Removing from Primary care) |
||
(22 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | '''For patient information click [[{{PAGENAME}} (patient information)|here]]''' | ||
{{Pituitary tumor}} | |||
{{CMG}}; {{AE}} {{MJM}}; {{Ammu}} | {{CMG}}; {{AE}} {{MJM}}; {{Ammu}} | ||
==Overview== | ==Overview== | ||
Pituitary tumors are [[Tumor|tumors]] that occur in the [[pituitary gland]] and account for about 10% of intracranial [[Neoplasia|neoplasms]]. Pituitary adenomas are often remain undiagnosed. Small pituitary tumors are found in 6 to 24 percent of adults at autopsy. Pituitary tumors arise within the anterior lobe (adenohypophysis) of the gland. They may be classified according to the size of the tumor and type of hormone secretion. Pituitary adenomas subtypes include [[corticotrophic]], [[somatotrophic]], [[thyrotrophic]], [[gonadotrophic]], and [[lactrotrophic]] adenomas. There are no established causes for pituitary tumors. Patients with pituitary tumors may progress to develop [[lethargy]], [[headache]], [[nausea]], and [[vomiting]]. Common complications of pituitary adenoma include [[bitemporal hemianopia]], [[anosmia]], [[acromegaly]], [[gigantism]], and [[Cushing's syndrome]]. Prognosis is generally good, and approximately 18% of patients with macroadenoma require further treatment. Pharmacologic medical therapy is recommended among patients with [[prolactinoma]], [[thyrotrophic]], [[somatotrophic]], and [[Adrenocorticotrophic hormone|adrenocorticotropic]] adenomas. The [[Sphenoid bone|transsphenoidal]] microsurgical approach is the mainstay of treatment for [[growth hormone]] producing adenomas, [[adrenocorticotropic hormone]]-(ACTH) producing adenomas, and macroadenomas. | |||
==Classification== | ==Classification== | ||
Pituitary tumors | Pituitary tumors classified according to the 2017 World Health Organization (WHO):<ref name="pmid28821944">{{cite journal| author=Lopes MBS| title=The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. | journal=Acta Neuropathol | year= 2017 | volume= 134 | issue= 4 | pages= 521-535 | pmid=28821944 | doi=10.1007/s00401-017-1769-8 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28821944 }}</ref>{{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{familytree | | | | | | | | | |,|-| A01 |-| A02 | | | |A01=[[Pituitary adenomas]] |A02=Somatotroph adenoma }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | |)|-| B01 |-| B02 | | | |B01=[[Pituitary carcinoma]] |B02= }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | |)|-| C01 |-| C02 | | | |C01=Pituitary blastoma |C02= }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | |)|-| D01 |-| D02 | | | |D01=Tumors of posterior pituitary |D02=Pituicytoma }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | E01 |-|+|-| E02 |-| E03 | | | |E01=Pituitary tumors |E02=[[Craniopharyngioma]] |E03=Adamantinomatous craniopharyngioma }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | |)|-| F01 |-| F02 | | | |F01=Mesenchymal and stromal tumors |F02=[[Meningioma]] }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | |)|-| G01 |-| G02 | | | |G01=Hematolymphoid tumors |G02= }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | |)|-| H01 |-| H02 | | | |H01=Germ cell tumors |H02=[[Germinoma]] }} | |||
{{familytree | | | | | | | | | |!| | | | | | | | | | | | | | | | | | }} | |||
{{familytree | | | | | | | | | |`|-| J01 |-| J02 | | | |J01=Secondary tumors |J02= }} | |||
{{familytree/end}} | |||
==Differential Diagnosis== | |||
{ | {| | ||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Disease}} | |||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Clinical Findings}} | |||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Laboratory Findings}} | |||
! style="background: #4479BA; text-align: center;" |{{fontcolor|#FFF|Management}} | |||
{{ | |- | ||
| style="background: #DCDCDC; text-align: center;" |[[Somatotroph adenoma]]: | |||
[[Acromegaly]] | |||
| style="background: #F5F5F5;" |Clinical features of [[acromegaly]] are due to high level of [[Growth hormone|human growth hormone]] ([[Growth hormone|hGH]]): | |||
* [[Soft tissue]] [[swelling]] of the hands and feet | |||
* Brow and lower jaw protrusion | |||
* Enlarged hands | |||
* Enlarged feet | |||
* [[Arthritis]] and [[carpal tunnel syndrome]] | |||
* Increase in teeth spacing | |||
* [[Macroglossia]] (enlarged tongue) | |||
* [[Heart failure]] | |||
* [[Kidney failure]] | |||
* Compression of the [[optic chiasma]] leading to loss of [[vision]] in the outer [[visual fields]] (typically [[bitemporal hemianopia]]) | |||
* [[Headache]] | |||
* [[Diabetes mellitus]] | |||
* [[Hypertension]] | |||
* [[Cardiomegaly]] | |||
| style="background: #F5F5F5;" | | |||
* Elevated [[insulin-like growth factor-1]] ([[Insulin-like growth factor-I|IGF-1]]) levels | |||
* Elevated [[growth hormone]] levels | |||
| style="background: #F5F5F5;" | | |||
* Medical management: | |||
** [[Octreotide]] | |||
** [[Bromocriptine]] | |||
* Surgical management: | |||
** Endonasal transsphenoidal surgery | |||
* [[Radiation therapy]] | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[ACTH-secreting tumor|Corticotroph adenoma]]: | |||
[[Cushing's syndrome]] | |||
| style="background: #F5F5F5;" |Clinical features of [[Cushing's syndrome]] are due to increased levels of [[cortisol]]: | |||
* Rapid [[Obesity|weight gain]], particularly of the [[trunk]] and face with sparing of the [[limbs]] ([[central obesity]]) | |||
* Proximal [[muscle weakness]] | |||
* A round face often referred to as a "[[moon face]]" | |||
* Excess [[sweating]] | |||
* [[Headache]] | |||
* The excess [[cortisol]] may also affect other endocrine systems and cause, for example: | |||
** [[Insomnia]] | |||
** Reduced [[libido]] | |||
** [[Impotence]] | |||
** [[Amenorrhea]] | |||
** [[Infertility]] | |||
* Patients frequently suffer various [[psychological]] disturbances, ranging from [[Euphoria (emotion)|euphoria]] to [[psychosis]]. [[Clinical depression|Depression]] and [[anxiety]] are also common. | |||
| style="background: #F5F5F5;" | | |||
* [[Dexamethasone suppression test]] | |||
* 24 hour urinary measurement of [[cortisol]] | |||
| style="background: #F5F5F5;" | | |||
* Medical management: | |||
** [[Pasireotide]] | |||
** [[Cabergoline]] | |||
** [[Ketoconazole]] | |||
** [[Metyrapone]] | |||
** [[Mitotane]] | |||
** [[Mifepristone]] | |||
* Surgical management: | |||
** Transsphenoidal [[Pituitary gland|pituitary]] resection | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Hypothyroidism]] | |||
| style="background: #F5F5F5;" |Clinical features of [[hypothyroidism]] are due to deficiency of [[thyroxine]]: | |||
* [[Fatigue]] | |||
* Cold intolerance | |||
* Decreased [[sweating]] | |||
* [[Hypothermia]] | |||
* Coarse [[skin]] | |||
* [[Weight gain]] | |||
* [[Hoarseness]] | |||
* [[Goiter]] | |||
* Fullness in the throat and neck | |||
* [[Depression]] | |||
* [[Emotional lability]] | |||
* [[Attention deficit]] | |||
| style="background: #F5F5F5;" | | |||
* Elevated [[Thyroid-stimulating hormone|TSH]] | |||
* Low [[Thyroxine|T4]] | |||
* Low [[Triiodothyronine|T3]] | |||
* Elevated anti-thyroid [[antibodies]](anti-TPO) | |||
| style="background: #F5F5F5;" | | |||
*[[Levothyroxine]] | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Chronic renal failure]] | |||
| style="background: #F5F5F5;" |There are no [[pathognomonic]] symptoms associated with [[chronic renal failure]]. Common non-specific symptoms of [[chronic renal failure]] include: | |||
* [[Malaise]] | |||
* [[Nausea]] | |||
* Unintentional [[weight loss]] | |||
* [[Pruritus]] | |||
* [[Lower extremity edema]] | |||
* [[Sleep disorders]] | |||
| style="background: #F5F5F5;" |[[Urinalysis]]: | |||
* [[Albuminuria]] | |||
* [[Hematuria]] | |||
* [[Pyuria]] | |||
* [[Red blood cell|Red cell]] or [[White blood cells|white cell]] [[casts]] and crystals | |||
[[Fluid and electrolytes|Fluid and electrolyte]] disturbances: | |||
* [[Hyponatremia]] | |||
* [[Hyperkalemia]] | |||
* [[Hyperphosphatemia]] | |||
* [[Hyperchloremia]] | |||
* [[Metabolic acidosis]] | |||
* [[Hypocalcemia]] | |||
[[Endocrine system|Endocrine]] and [[metabolic]] disturbances: | |||
* [[Hyperuricemia]] | |||
* [[Hypertriglyceridemia]] | |||
* Decreased [[HDL]] levels | |||
* [[Vitamin D deficiency]] | |||
* Increased [[Parathyroid hormone]] levels | |||
[[Hematologic]] abnormalities: | |||
* [[Normocytic normochromic anemia]] | |||
* [[Lymphocytopenia]] | |||
* [[Leukopenia]] | |||
* [[Thrombocytopenia]] | |||
| style="background: #F5F5F5;" | | |||
* Medical management: | |||
** [[Blood pressure medication|Blood pressure management]] | |||
** Control of [[Blood sugar|blood glucose]] | |||
** [[Protein]] restriction | |||
** Management of [[anemia]] | |||
** Management of [[electrolyte disturbance]] | |||
** [[Dialysis]] | |||
* Surgical management | |||
** [[Kidney transplant]] | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Cirrhosis|Liver disease: Cirrhosis]] | |||
| style="background: #F5F5F5;" |The clinical features of liver [[cirrhosis]] are very nonspecific. These include: | |||
* [[Right upper quadrant (abdomen)|Right upper quadrant]] [[abdominal pain]] | |||
* [[Fever]] | |||
* [[Fatigue]] and [[weakness]] | |||
* [[Loss of appetite]] | |||
* [[Diarrhea]] | |||
* [[Nausea]] and [[vomiting]] | |||
* [[Weight loss]] | |||
* [[Abdominal pain]] and [[bloating]] when fluid accumulates in the [[abdomen]] | |||
* [[Itching]] | |||
* [[Menstrual cycle|Menstrual]] irregularities | |||
| style="background: #F5F5F5;" | | |||
*Elevated [[aminotransferases]] ([[Aspartate transaminase|AST]] & [[Alanine transaminase|ALT]]) | |||
*Elevated [[alkaline phosphatase]] ([[Alkaline phosphatase|ALP]]) | |||
*Elevated [[gamma-glutamyl transpeptidase]] | |||
*Elevated [[bilirubin]] | |||
*Low [[albumin]] | |||
*Elevated [[prothrombin time]] | |||
*Elevated [[globulin]] | |||
*[[Hyponatremia]] | |||
*[[Anemia]] | |||
*[[Leukopenia]] and [[neutropenia]] | |||
*[[Thrombocytopenia]] | |||
| style="background: #F5F5F5;" | | |||
* Medical management: | |||
** Treatment is usually directed towards the treatment of complications like [[ascites]], [[esophageal varices]], [[hepatic encephalopathy]], [[hepatorenal syndrome]], and [[spontaneous bacterial peritonitis]]. | |||
*** Some chronic constitutional [[symptoms]] that should be treated include: | |||
**** [[Pruritis]]: [[Cholestyramine]] is the drug of choice | |||
**** [[Hypogonadism]]: Topical [[testosterone]] preparations | |||
**** [[Osteoporosis]]: [[Calcium]] and [[vitamin D]] | |||
**** Pain management: [[Non-steroidal anti-inflammatory drug|NSAIDS]], [[celecoxib]], [[opioids]] | |||
**** Nutrition: Adequate [[Calories|caloric]] and [[protein]] intake, and [[multivitamin]] supplementation | |||
* Surgical management: [[Liver transplantation]] | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Seizure|Seizure disorder]] | |||
| style="background: #F5F5F5;" |The clinical features of [[seizure disorder]] may include: | |||
* Change in [[alertness]], orientation and time perception | |||
* Mood changes, such as unexplainable fear, panic, joy, or laughter | |||
* Changes in sensation of the [[skin]], usually spreading over the [[arm]], [[Leg (anatomy)|leg]], or [[trunk]] | |||
* [[Vision]] changes, including seeing flashing lights | |||
* Rarely, [[Hallucination|hallucinations]] (seeing things that aren't there) | |||
* Falling, loss of [[muscle]] control, occurs very suddenly | |||
* [[Muscle twitching]] that may spread up or down an [[arm]] or [[leg]] | |||
* [[Muscle]] tension or tightening that causes twisting of the body, [[head]], [[Arm|arms]], or [[legs]] | |||
* Shaking of the entire body | |||
* Tasting a bitter or metallic flavor | |||
| style="background: #F5F5F5;" | | |||
*[[Electroencephalogram]] | |||
| style="background: #F5F5F5;" | | |||
* Medical management: | |||
** [[Antiepileptics|Antiepileptic]] medications | |||
|- | |||
| style="background: #DCDCDC; text-align: center;" |[[Medication-induced]] | |||
| style="background: #F5F5F5;" |Clinical features of [[hyperprolactinemia]] after a specific period of regular medication ingestion | |||
| style="background: #F5F5F5;" | | |||
*Discontinuation of the medication for 3 days and remeasurement of [[prolactin]] levels<ref name="pmid21296991">{{cite journal| author=Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA et al.| title=Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. | journal=J Clin Endocrinol Metab | year= 2011 | volume= 96 | issue= 2 | pages= 273-88 | pmid=21296991 | doi=10.1210/jc.2010-1692 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21296991 }}</ref> | |||
| style="background: #F5F5F5;" | | |||
*Change to alternate medication | |||
|} | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
{{WH}} | |||
{{WS}} | |||
[[Category:Disease]] | [[Category:Disease]] | ||
Line 22: | Line 226: | ||
[[Category:Thyroid disease]] | [[Category:Thyroid disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
Latest revision as of 23:43, 29 July 2020
For patient information click here
Pituitary Tumor Microchapters |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Michael Maddaleni, B.S.; Ammu Susheela, M.D. [2]
Overview
Pituitary tumors are tumors that occur in the pituitary gland and account for about 10% of intracranial neoplasms. Pituitary adenomas are often remain undiagnosed. Small pituitary tumors are found in 6 to 24 percent of adults at autopsy. Pituitary tumors arise within the anterior lobe (adenohypophysis) of the gland. They may be classified according to the size of the tumor and type of hormone secretion. Pituitary adenomas subtypes include corticotrophic, somatotrophic, thyrotrophic, gonadotrophic, and lactrotrophic adenomas. There are no established causes for pituitary tumors. Patients with pituitary tumors may progress to develop lethargy, headache, nausea, and vomiting. Common complications of pituitary adenoma include bitemporal hemianopia, anosmia, acromegaly, gigantism, and Cushing's syndrome. Prognosis is generally good, and approximately 18% of patients with macroadenoma require further treatment. Pharmacologic medical therapy is recommended among patients with prolactinoma, thyrotrophic, somatotrophic, and adrenocorticotropic adenomas. The transsphenoidal microsurgical approach is the mainstay of treatment for growth hormone producing adenomas, adrenocorticotropic hormone-(ACTH) producing adenomas, and macroadenomas.
Classification
Pituitary tumors classified according to the 2017 World Health Organization (WHO):[1]
Pituitary adenomas | Somatotroph adenoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pituitary carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pituitary blastoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Tumors of posterior pituitary | Pituicytoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pituitary tumors | Craniopharyngioma | Adamantinomatous craniopharyngioma | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Mesenchymal and stromal tumors | Meningioma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Hematolymphoid tumors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Germ cell tumors | Germinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary tumors | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Differential Diagnosis
Disease | Clinical Findings | Laboratory Findings | Management |
---|---|---|---|
Somatotroph adenoma: | Clinical features of acromegaly are due to high level of human growth hormone (hGH):
|
|
|
Corticotroph adenoma: | Clinical features of Cushing's syndrome are due to increased levels of cortisol:
|
|
|
Hypothyroidism | Clinical features of hypothyroidism are due to deficiency of thyroxine:
|
|
|
Chronic renal failure | There are no pathognomonic symptoms associated with chronic renal failure. Common non-specific symptoms of chronic renal failure include:
|
Urinalysis:
Fluid and electrolyte disturbances: Endocrine and metabolic disturbances:
Hematologic abnormalities: |
|
Liver disease: Cirrhosis | The clinical features of liver cirrhosis are very nonspecific. These include:
|
|
|
Seizure disorder | The clinical features of seizure disorder may include:
|
| |
Medication-induced | Clinical features of hyperprolactinemia after a specific period of regular medication ingestion |
|
References
- ↑ Lopes MBS (2017). "The 2017 World Health Organization classification of tumors of the pituitary gland: a summary". Acta Neuropathol. 134 (4): 521–535. doi:10.1007/s00401-017-1769-8. PMID 28821944.
- ↑ Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA; et al. (2011). "Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline". J Clin Endocrinol Metab. 96 (2): 273–88. doi:10.1210/jc.2010-1692. PMID 21296991.